FTC and four states sue transgender health group over marketing of youth care
The Federal Trade Commission and the attorneys general of Alaska, Iowa, Nebraska and Texas filed suit against the World Professional Association for Transgender Health in federal court in the Northern District of Texas on June 17. The complaint alleges WPATH made deceptive statements in marketing surgeries and drugs to minors, including portraying its treatment guidelines as resting on “strong evidence derived from scientific methods.” To support its safety claims, the government leans on England’s Cass review and the Trump administration’s own review of gender dysphoria.
WPATH rejected the allegations, arguing the FTC lacks jurisdiction over what it calls noncommercial speech and has no role in clinical decision-making. The group last month won a First Amendment challenge to an FTC subpoena in D.C. district court.
The case is notable less for the specific claims than for the legal theory: it treats a medical society’s clinical guidelines as commercial advertising subject to consumer-protection law. If that framing survives WPATH’s jurisdictional and First Amendment defenses, it would give federal regulators a route to police medical guidance well beyond this dispute; if it fails, as the earlier subpoena ruling suggests it might, the suit functions mainly as political pressure on a contested area of care.